Yan-Ruide Li

21PUBLICATIONS
55CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMedical molecular engineering of nucleic acids and proteinsElectrical energy generation (incl. renewables, excl. photovoltaics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 13, 2026
Targeting CCR1/CCR2 attenuates cytokine release syndrome while preserving CAR T-cell antitumor activity.

|Jun 15, 2026
Rejuvenated Hematopoietic Stem and Progenitor Cell-Engineered CAR-Armored Natural Killer T Cells for Malignant Pleural Mesothelioma.

|Apr 16, 2026
Universal Nanovial Screening Enables Functional Discovery of Metabolite-Reactive T-Cell Receptors for Cancer Therapy.

|Mar 27, 2026
Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemia.

Yan-Ruide Li, Xinyuan Shen, Yuning Chen

|Mar 18, 2026
Engineering an in vivo charging station for CAR-redirected invariant natural killer T cells to enhance cancer therapy.

Yan-Ruide Li, Haochen Nan, Zeyang Liu

|Mar 14, 2026
Spatiotemporal profiling reveals distinct dynamics and checkpoint regulations of CAR-T and CAR-NKT cells against solid tumors.

Yan-Ruide Li, Miao Li, Yuning Chen

Pageof 4

Frequent Collaborators

10 joint publications

Lili Yang

7 joint publications

Enbo Zhu

6 joint publications

Tzung K Hsiai

4 joint publications

Xinyuan Shen